119 related articles for article (PubMed ID: 30579121)
1. Discovery of novel nonsteroidal VDR agonists with novel diarylmethane skeleton for the treatment of breast cancer.
Wang C; Wang B; Hou S; Xue L; Kang Z; Du J; Li Y; Liu X; Wang Q; Zhang C
Eur J Med Chem; 2019 Feb; 163():787-803. PubMed ID: 30579121
[TBL] [Abstract][Full Text] [Related]
2. Sulfonyl-containing phenyl-pyrrolyl pentane analogues: Novel non-secosteroidal vitamin D receptor modulators with favorable physicochemical properties, pharmacokinetic properties and anti-tumor activity.
Kang ZS; Wang C; Han XL; Wang B; Yuan HL; Hou SY; Hao MX; Du JJ; Li YY; Zhou AW; Zhang C
Eur J Med Chem; 2018 Sep; 157():1174-1191. PubMed ID: 30193216
[TBL] [Abstract][Full Text] [Related]
3. Novel nonsecosteroidal VDR ligands with phenyl-pyrrolyl pentane skeleton for cancer therapy.
Ge Z; Hao M; Xu M; Su Z; Kang Z; Xue L; Zhang C
Eur J Med Chem; 2016 Jan; 107():48-62. PubMed ID: 26562542
[TBL] [Abstract][Full Text] [Related]
4. Further Developments of the Phenyl-Pyrrolyl Pentane Series of Nonsteroidal Vitamin D Receptor Modulators as Anticancer Agents.
Hao M; Hou S; Xue L; Yuan H; Zhu L; Wang C; Wang B; Tang C; Zhang C
J Med Chem; 2018 Apr; 61(7):3059-3075. PubMed ID: 29518319
[TBL] [Abstract][Full Text] [Related]
5. Novel nonsecosteroidal VDR agonists with phenyl-pyrrolyl pentane skeleton.
Shen W; Xue J; Zhao Z; Zhang C
Eur J Med Chem; 2013 Nov; 69():768-78. PubMed ID: 24099996
[TBL] [Abstract][Full Text] [Related]
6. Identification of Novel Non-secosteroidal Vitamin D Receptor Agonists with Potent Cardioprotective Effects and devoid of Hypercalcemia.
Khedkar SA; Samad MA; Choudhury S; Lee JY; Zhang D; Thadhani RI; Karumanchi SA; Rigby AC; Kang PM
Sci Rep; 2017 Aug; 7(1):8427. PubMed ID: 28814738
[TBL] [Abstract][Full Text] [Related]
7. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.
Boehm MF; Fitzgerald P; Zou A; Elgort MG; Bischoff ED; Mere L; Mais DE; Bissonnette RP; Heyman RA; Nadzan AM; Reichman M; Allegretto EA
Chem Biol; 1999 May; 6(5):265-75. PubMed ID: 10322128
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D-induced vitamin D receptor expression induces tamoxifen sensitivity in MCF-7 stem cells via suppression of Wnt/β-catenin signaling.
Zheng W; Duan B; Zhang Q; Ouyang L; Peng W; Qian F; Wang Y; Huang S
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30314996
[No Abstract] [Full Text] [Related]
9. 1,25-Dihydroxyvitamin D
Li M; Li L; Zhang L; Hu W; Shen J; Xiao Z; Wu X; Chan FL; Cho CH
Life Sci; 2017 Jun; 179():88-97. PubMed ID: 28465245
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of noncalcemic, tissue-selective, nonsecosteroidal vitamin D receptor modulators.
Ma Y; Khalifa B; Yee YK; Lu J; Memezawa A; Savkur RS; Yamamoto Y; Chintalacharuvu SR; Yamaoka K; Stayrook KR; Bramlett KS; Zeng QQ; Chandrasekhar S; Yu XP; Linebarger JH; Iturria SJ; Burris TP; Kato S; Chin WW; Nagpal S
J Clin Invest; 2006 Apr; 116(4):892-904. PubMed ID: 16528410
[TBL] [Abstract][Full Text] [Related]
11. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
12. Effects of fluorines on nonsecosteroidal vitamin D receptor agonists.
Kashiwagi H; Ohta M; Ono Y; Morikami K; Itoh S; Sato H; Takahashi T
Bioorg Med Chem; 2013 Feb; 21(3):712-21. PubMed ID: 23266184
[TBL] [Abstract][Full Text] [Related]
13. Benzofuran-2-acetic ester derivatives induce apoptosis in breast cancer cells by upregulating p21
Giordano C; Rovito D; Barone I; Mancuso R; Bonofiglio D; Giordano F; Catalano S; Gabriele B; Andò S
DNA Repair (Amst); 2017 Mar; 51():20-30. PubMed ID: 28108275
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer.
Thakkar A; Wang B; Picon-Ruiz M; Buchwald P; Ince TA
Breast Cancer Res Treat; 2016 May; 157(1):77-90. PubMed ID: 27120467
[TBL] [Abstract][Full Text] [Related]
15. VDR Agonists Increase Sensitivity of MCF-7 and BT-474 Breast Cancer Cells to 5 FU.
Klopotowska D; Matuszyk J
Anticancer Res; 2020 Feb; 40(2):837-840. PubMed ID: 32014926
[TBL] [Abstract][Full Text] [Related]
16. A novel anthracene derivative, MHY412, induces apoptosis in doxorubicin-resistant MCF-7/Adr human breast cancer cells through cell cycle arrest and downregulation of P-glycoprotein expression.
De U; Chun P; Choi WS; Lee BM; Kim ND; Moon HR; Jung JH; Kim HS
Int J Oncol; 2014 Jan; 44(1):167-76. PubMed ID: 24190517
[TBL] [Abstract][Full Text] [Related]
17. Cdx2 polymorphism affects the activities of vitamin D receptor in human breast cancer cell lines and human breast carcinomas.
Pulito C; Terrenato I; Di Benedetto A; Korita E; Goeman F; Sacconi A; Biagioni F; Blandino G; Strano S; Muti P; Mottolese M; Falvo E
PLoS One; 2015; 10(4):e0124894. PubMed ID: 25849303
[TBL] [Abstract][Full Text] [Related]
18. Coenzyme Q
Wang HM; Yang HL; Thiyagarajan V; Huang TH; Huang PJ; Chen SC; Liu JY; Hsu LS; Chang HW; Hseu YC
Integr Cancer Ther; 2017 Sep; 16(3):385-396. PubMed ID: 27821721
[TBL] [Abstract][Full Text] [Related]
19. Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function.
Saxena R; Gupta G; Manohar M; Debnath U; Popli P; Prabhakar YS; Konwar R; Kumar S; Kumar A; Dwivedi A
Int J Biochem Cell Biol; 2016 Jan; 70():105-17. PubMed ID: 26556313
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationship of nonsecosteroidal vitamin D receptor modulators.
Yamada S; Makishima M
Trends Pharmacol Sci; 2014 Jul; 35(7):324-37. PubMed ID: 24865943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
